fluorouracil has been researched along with jte 013 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, S; Guo, Z; Han, G; Liu, S; Liu, X; Luo, D; Lv, Y; Qu, X; Tian, X; Wan, S; Wang, W; Yang, S; Zhang, Y | 1 |
| Luo, DD; Qu, XJ; Wan, SB; Zhang, YH | 1 |
2 other study(ies) available for fluorouracil and jte 013
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cells, Cultured; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Molecular Structure; Sphingosine-1-Phosphate Receptors; Structure-Activity Relationship | 2021 |
S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Down-Regulation; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mice, Nude; Molecular Docking Simulation; Pyrazoles; Pyridines; Sphingosine-1-Phosphate Receptors | 2020 |